News Search Results
Nov 10, 2025, 08:00 ET Servier's Clinical and Real-World Data at 2025 SNO Congress Showcase Leadership in IDH-Mutant Glioma
liver enzyme levels in the blood lack of energy, tiredness headache COVID-19 muscle aches or stiffness diarrhea nausea
More news about: Servier Pharmaceuticals
Nov 10, 2025, 05:05 ET De l'innovation pandémique à la collaboration mondiale : la MTC de Taïwan brille au CPHI Frankfurt 2025
des effets antiviraux et anti-inflammatoires multicibles, réduisant les admissions en soins intensifs et la mortalité chez les patients atteints de COVID-19 tout en protégeant contre les lésions pulmonaires et le brouillard cérébral post-infectieux. Les entreprises taïwanaises participantes,
More news about: Taiwan Institute of Economic Research
Nov 10, 2025, 05:05 ET Von der Pandemie-Innovation zur globalen Zusammenarbeit: Taiwans TCM glänzt auf der CPHI Frankfurt 2025
antivirale und entzündungshemmende Wirkungen aufweisen, welche die Zahl der Einweisungen auf die Intensivstation sowie die Sterblichkeitsquote bei COVID-19-Patienten senken und gleichzeitig vor Lungenverletzungen sowie postinfektiösen kognitiven Einschränkungen nach der Infektion (auch Brain Fog genannt)
More news about: Taiwan Institute of Economic Research
Nov 10, 2025, 05:04 ET De innovación pandémica a colaboración global: la medicina tradicional china brilla en CPHI Frankfurt 2025
fórmulas han demostrado efectos antivirales y antiinflamatorios multiobjetivo, reduciendo los ingresos en la UCI y la mortalidad en pacientes con COVID-19, a la vez que protegen contra la lesión pulmonar y la confusión mental posterior a la infección. Las empresas taiwanesas participantes
More news about: Taiwan Institute of Economic Research
Nov 07, 2025, 21:32 ET Pfizer and Metsera Enter into Merger Agreement Amendment; Metsera's Board of Directors Reaffirms Support of Merger with Pfizer
processes, safety and/or other matters that could affect the availability or commercial potential of such products; uncertainties regarding the impact of COVID-19; and competitive developments. You should carefully consider the foregoing factors
More news about: Metsera, Inc.
Nov 07, 2025, 07:30 ET Soligenix Announces Recent Accomplishments and Third Quarter 2025 Financial Results
candidate, as well as our vaccine programs targeting filoviruses (such as Marburg and Ebola) and CiVax™, our vaccine candidate for the prevention of COVID-19 (caused by SARS-CoV-2). The development of our vaccine programs incorporates the use of our proprietary heat stabilization platform technology, known
More news about: SOLIGENIX, INC.
Nov 07, 2025, 06:30 ET Metering Pumps Market worth $9.1 billion by 2030 - Exclusive Report by MarketsandMarkets™
processes. Such pumps are being progressively employed in precision-oriented applications, such as vial filling systems and ventilators. After the COVID-19 pandemic, pharmaceutical manufacturing has been able to maintain high production levels, which is driving the demand for pumps. Peristaltic pumps
More news about: MarketsandMarkets
Nov 06, 2025, 18:00 ET Mountain Province Diamonds Announces Third Quarter 2025 Production and Sales Results, Update on Guidance, Details of Third Quarter 2025 Earnings Release, and Conference Call
forward-looking statements include the development of operation hazards which could arise in relation to COVID-19, including, but not limited to protocols which may be adopted to reduce the spread of COVID-19 and any impact of such protocols on Mountain Province's business and operations, variations in ore
More news about: Mountain Province Diamonds Inc.
Nov 06, 2025, 16:15 ET Brookdale Announces Third Quarter 2025 Results and Increases Adjusted EBITDA Annual Guidance
including initiatives undertaken to execute on the Company's strategic priorities and their effect on its results; any resurgence or variants of the COVID-19 pandemic; limits on the Company's ability to use net operating loss carryovers to reduce future tax payments; delays in obtaining regulatory approvals;
More news about: Brookdale Senior Living Inc.
Nov 06, 2025, 16:05 ET LIONSGATE REPORTS RESULTS FOR SECOND QUARTER FISCAL 2026
share-based compensation, certain content charges as a result of changes in management and/or content strategy, certain benefits or expenses related to the COVID-19 global pandemic, unallocated rent cost and purchase accounting and related adjustments. The Company believes the presentation of Studio Business segment
More news about: Lionsgate
Nov 06, 2025, 11:00 ET Securities Lending Market to Reach $12,157.3 Million In 2024 in The Short Term And $21,499.9 Million By 2034 globally, At 5.7% CAGR: Allied Market Research
(Latin America, Middle East, Africa) Trending Reports in BFSI Industry (Book Now with 10% Discount + COVID-19 Scenario):
More news about: Allied Market Research
Nov 06, 2025, 10:01 ET IoT Market worth $865.20 billion by 2030 | MarketsandMarkets™
reducing hospital visits. Hospitals are deploying IoT for asset management, staff coordination, and predictive maintenance of medical equipment. The COVID-19 pandemic further accelerated the adoption of telemedicine and connected health solutions. With advancements in 5G, edge computing, and AI analytics,
More news about: MarketsandMarkets
Nov 06, 2025, 08:00 ET Novavax Reports Third Quarter 2025 Financial Results and Operational Highlights
approved the Nuvaxovid 2025-2026 Formula for the prevention of COVID-19 in individuals 65 years of age and older, or 12 years through 64 years of age with at least one underlying condition that puts them at high risk for severe outcomes from COVID-19. Nuvaxovid was approved with an extended shelf life of six
More news about: Novavax, Inc.
Nov 06, 2025, 07:00 ET Lightspeed Announces Second Quarter 2026 Financial Results and Raises Outlook for Fiscal 2026
jurisdictions in which Lightspeed has significant operations do not impose strict measures like those put in place in response to pandemics like the COVID-19 pandemic or other health crises; requests for subscription pauses and churn rates owing to business failures remain in line with planned levels; our
More news about: Lightspeed Commerce Inc.
Nov 06, 2025, 06:59 ET Cogent Communications Reports Third Quarter 2025 Results
Wireline Business and the related costs continuing for a longer period than expected; transition related costs associated with the acquisition; the COVID-19 pandemic and the related government policies; future economic instability in the global economy, including the risk of economic recession, recent
More news about: Cogent Communications Holdings, Inc.
Nov 06, 2025, 06:30 ET United Parks & Resorts Inc. Reports Third Quarter and First Nine Months 2025 Results
temporary COVID-19 park closures. For the twelve months ended September 30, 2025, primarily reflects a reversal of costs, which had previously been accrued, associated with nonrecurring contractual liabilities and respective assessments related to the previously disclosed temporary COVID-19 park closures.
More news about: United Parks and Resorts Inc.
Nov 05, 2025, 19:17 ET Metsera Issues Statement in Response to Litigation Ruling
processes, safety and/or other matters that could affect the availability or commercial potential of such products; uncertainties regarding the impact of COVID-19; and competitive developments. You should carefully consider the foregoing factors
More news about: Metsera, Inc.
Nov 05, 2025, 16:05 ET QuidelOrtho Reports Third Quarter 2025 Financial Results
― Total revenue of $700 million; excluding COVID-19 and Donor Screening, revenue grew mid-single digits, demonstrating solid underlying growth and momentum ―
More news about: QuidelOrtho Corporation
Nov 05, 2025, 16:01 ET Dynavax Reports Third Quarter 2025 Financial Results and Announces New $100 Million Share Repurchase Program
need for easily administered COVID-19 vaccine options. Vaxart's oral vaccine candidate has a novel mechanism of action and delivery method relative to commercially available COVID-19 vaccines, an approach with the potential to transform the multi-billion-dollar COVID-19 vaccine market opportunity.
More news about: Dynavax Technologies
Nov 05, 2025, 16:00 ET Dynavax Enters Exclusive License Agreement for Vaxart's Novel Oral COVID-19 Vaccine Program
Vaxart is conducting a randomized, double-blind, multi-center trial comparing its oral COVID-19 vaccine candidate against an FDA-approved mRNA COVID-19 injectable vaccine in adults previously immunized against COVID-19. The primary endpoint is the relative efficacy of Vaxart's candidate compared to the
More news about: Dynavax Technologies
Nov 05, 2025, 13:07 ET Many More Clinical Trials Needed: the State of Cannabidiol Research
the University of Chicago and University of Louisville, where an interdisciplinary team is investigating CBD's potential as a preventative for the COVID-19 virus; the University of Northern Colorado, where a researcher is examining a possible connection between CBD and immune function; the Douglas Research
More news about: Fusion CBD Products
Nov 05, 2025, 10:45 ET The global travel insurance market size was valued at $23.8 billion in 2024, and is projected to reach $132.9 billion by 2034, growing at a CAGR of 18.4% from 2025 to 2034
(Latin America, Middle East, Africa) Trending Reports in BFSI Industry (Book Now with 10% Discount + COVID-19 Scenario):
More news about: Allied Market Research
Nov 05, 2025, 10:31 ET ShipTime and Canadian Federation of Independent Business (CFIB) Expand Long-Standing Partnership to Deliver Game-Changing Benefits for Canadian Small Businesses
CFIB's work has been especially critical during times of uncertainty and disruption. From supporting small businesses through COVID-19, to standing up for them during postal strikes, border slowdowns, and trade challenges, CFIB has consistently been on the frontlines
More news about: ShipTime Canada Inc.
Nov 05, 2025, 08:44 ET IQ AIR: A Supplement Designed to Strengthen Lung Health
CNN Health also reports that as the fall chill sets in, the threat of respiratory viruses "like Covid-19, influenza, or RSV looms across the country." The number of lung-related respiratory illnesses that humans face each year during
More news about: LifeBridge
Nov 05, 2025, 07:55 ET Sempra Reports Third-Quarter 2025 Results
$(25) million impact from regulatory disallowances related to the recovery of coronavirus disease 2019 (COVID-19) costs at Sempra California $(121) million impact from foreign currency and inflation on our monetary positions in Mexico
More news about: Sempra